Organ and Tissue Transplantation Strategic Research Report 2023-2030: Rising Focus on Immunosuppressive Therapies Strengthens Business Case for Post-Transplant Care [Yahoo! Finance]
Artivion, Inc. (AORT)
Company Research
Source: Yahoo! Finance
Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Organ and Tissue Transplantation is estimated at US$20.0 Billion in 2023 and is projected to reach US$37.2 Billion by 2030, growing at a CAGR of 9.2% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The growth in the organ and tissue transplantation market is driven by several factors. Increasing incidences of organ failure and the resultant rise in the number of patients on transplant waiting lists directly impact demand for transplantation services. Innovations in surgical technologies and immunosuppressive medications have improved the success rates of transplant surgeries, encouraging more individuals to opt for these life-saving procedures. Additionally, enhanced public awareness and governmental initiatives promoting organ donation have increased the avail
Show less
Read more
Impact Snapshot
Event Time:
AORT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AORT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AORT alerts
High impacting Artivion, Inc. news events
Weekly update
A roundup of the hottest topics
AORT
News
- Artivion Inc (AORT) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advances [Yahoo! Finance]Yahoo! Finance
- Artivion, Inc. (NYSE: AORT) had its price target raised by analysts at Oppenheimer Holdings Inc. from $30.00 to $32.00. They now have an "outperform" rating on the stock.MarketBeat
- Artivion Reports Third Quarter 2024 Financial ResultsPR Newswire
- Artivion to Participate in Upcoming Investor ConferencesPR Newswire
- Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial ResultsPR Newswire
AORT
Earnings
- 11/7/24 - Beat
AORT
Sec Filings
- 11/8/24 - Form 10-Q
- 11/8/24 - Form SC
- 11/8/24 - Form SC
- AORT's page on the SEC website